Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Accured Expenses (2016 - 2025)

Utah Medical Products has reported Change in Accured Expenses over the past 16 years, most recently at -$566000.0 for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$566000.0 for Q4 2025, down 1186.36% from a year ago — trailing twelve months through Dec 2025 was -$1.4 million (up 9.04% YoY), and the annual figure for FY2025 was -$1.4 million, up 9.04%.
  • Change in Accured Expenses for Q4 2025 was -$566000.0 at Utah Medical Products, down from $729000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for UTMD hit a ceiling of $1.4 million in Q3 2022 and a floor of -$1.9 million in Q2 2025.
  • Median Change in Accured Expenses over the past 5 years was -$100000.0 (2021), compared with a mean of -$166450.0.
  • Biggest five-year swings in Change in Accured Expenses: crashed 1536.36% in 2021 and later skyrocketed 207.68% in 2025.
  • Utah Medical Products' Change in Accured Expenses stood at -$98000.0 in 2021, then crashed by 739.8% to -$823000.0 in 2022, then skyrocketed by 60.02% to -$329000.0 in 2023, then skyrocketed by 86.63% to -$44000.0 in 2024, then tumbled by 1186.36% to -$566000.0 in 2025.
  • The last three reported values for Change in Accured Expenses were -$566000.0 (Q4 2025), $729000.0 (Q3 2025), and -$1.9 million (Q2 2025) per Business Quant data.